NCT03739866 Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults Status COMPLETED Phase PHASE1
NCT03725761 Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03701438 Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib Status TERMINATED Phase N/A
NCT03696290 Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis Status TERMINATED Phase PHASE4
NCT03693040 Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP) Status UNKNOWN Phase NA
NCT03639324 Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL Status WITHDRAWN Phase PHASE1
NCT03631732 Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants Status COMPLETED Phase PHASE3
NCT03628677 A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03615066 Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment Status COMPLETED Phase PHASE2
NCT03607396 Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT03602560 ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) Status COMPLETED Phase PHASE3
NCT03595527 Universal HIV Screening and Targeted HCV Screening in Emergency Department Status COMPLETED Phase NA
NCT03582098 Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland Status COMPLETED Phase N/A
NCT03581383 Community Access, Retention in Care, and Engagement for Hepatitis C Treatment Status COMPLETED Phase NA
NCT03580668 Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide Status COMPLETED Phase N/A
NCT03577197 Southeast Netherlands Advanced Metastatic Breast Cancer Registry Status RECRUITING Phase N/A